March 31, 2026

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 122% Potential Upside in Biotech Innovation

ImmunityBio, Inc. (NASDAQ: IBRX), a trailblazer in the biotech sector, is capturing investor attention with its focus on cutting-edge immunotherapies aimed at bolstering the body’s immune response against cancer and..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 149.77% Potential Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.75 billion, the company is carving..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating a Potential 74.90% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the drug manufacturing industry, offers a compelling opportunity for investors seeking exposure in the healthcare sector. With its headquarters in Dublin,..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A 125% Potential Upside Amid Impressive Revenue Growth

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its remarkable revenue growth and a compelling potential upside of 125.40%. As a biotechnology company headquartered in Durham,..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 45.69% Potential Upside

ICU Medical, Inc. (NASDAQ: ICUI), a leader in the healthcare sector, operates within the Medical Instruments & Supplies industry, offering a broad array of products designed for infusion therapy, vascular..

Scholar Rock Holding Corporation (SRRK): Investor Outlook Reveals 30% Upside Potential in Biotech Sector

Investor interest in the biotechnology sector continues to gain momentum, and Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out with a promising 30.16% potential upside, according to recent analyst ratings...

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 42.98% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with a market capitalization of $2.92 billion. As a company focused on delivering innovative treatments for rare diseases, investors..

Veracyte, Inc. (VCYT) Stock Analysis: 54.40% Potential Upside Beckons Investors

Veracyte, Inc. (NASDAQ: VCYT), a key player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in the biotech hub of South San Francisco, California, Veracyte is..

Privia Health Group, Inc. (PRVA) Stock Analysis: Examining a 59.59% Potential Upside in Healthcare

Privia Health Group, Inc. (NASDAQ: PRVA) is garnering significant attention from investors, thanks to an impressive potential upside of nearly 60% based on analyst targets. As a leading player in..

Organon & Co. (OGN) Stock Analysis: Unpacking the 57.89% Potential Upside for Healthcare Investors

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, focuses on providing women’s health solutions and a range of pharmaceutical products across the globe. With a market..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 30% Upside Potential

LivaNova PLC (LIVN), a pioneering name in the healthcare sector, operates within the medical devices industry and is headquartered in London, United Kingdom. With a market capitalization of $3.35 billion,..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 54% Potential Upside

Ardent Health, Inc. (ARDT), a key player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $1.18 billion, the..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Unveiling a 40% Potential Upside in a Promising Biotech Sector

For investors with an appetite for high-growth opportunities in the biotechnology sector, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing prospect. With a market capitalization of $8.07 billion, the company..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31.78% Potential Upside Amidst Strategic Collaborations

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its compelling market dynamics and promising pipeline of treatments for rare disorders. With..

Sotera Health Company (SHC) Stock Analysis: Exploring a 56.60% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands as a formidable entity within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $3.77 billion, it has carved out..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a Potential 43% Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to eyewear retailing. With a market capitalization of $2.49 billion,..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Market Dynamics with a Potential 18% Upside

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector, particularly within the medical instruments and supplies industry, offers a compelling case for investors looking to tap into..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a Pioneering Path in Biotechnology with a -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology firm based in New York, is carving a niche in the healthcare sector with its innovative hormone analog peptides aimed at treating obesity..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring Its 171.76% Potential Upside

Ultragenyx Pharmaceutical Inc. (RARE), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 171.76%. Specializing in the development and commercialization of treatments for..

FTSE 100 gains as energy and mining stocks stay in focus

The FTSE 100 rose again as investors backed mining and energy stocks, with geopolitics and commodity prices continuing to shape the UK market...
Search

Funds

March 31, 2026

FTSE 100 gains as energy and mining stocks stay in focus

The FTSE 100 rose again as investors backed mining and energy stocks, with geopolitics and commodity prices continuing to shape the UK market...
Search

Funds

March 31, 2026

FTSE 100

Funds